PCTC
PFE icon

Perkins Coie Trust Company’s Pfizer PFE Stock Holding History

Perkins Coie Trust Company’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Buy
63,473
+747
+1% +$19.5K 0.25% 62
2026
Q1 		$1.76M Sell
62,726
-685
-1% -$18.2K 0.34% 59
2025
Q4 		$1.58M Sell
63,411
-11,044
-15% -$279K 0.29% 60
2025
Q3 		$1.9M Sell
74,455
-3,374
-4% -$83.3K 0.36% 58
2025
Q2 		$1.89M Sell
77,829
-5,999
-7% -$140K 0.32% 59
2025
Q1 		$2.12M Sell
83,828
-15,908
-16% -$416K 0.48% 55
2024
Q4 		$2.64M Sell
99,736
-14,292
-13% -$388K 0.58% 51
2024
Q3 		$3.3M Sell
114,028
-2,112
-2% -$61.6K 0.73% 46
2024
Q2 		$3.25M Sell
116,140
-355
-0.3% -$9.77K 0.76% 43
2024
Q1 		$3.23M Buy
116,495
+5,185
+5% +$144K 0.76% 46
2023
Q4 		$3.2M Buy
111,310
+8,846
+9% +$267K 0.81% 40
2023
Q3 		$3.4M Buy
102,464
+8,052
+9% +$285K 0.96% 35
2023
Q2 		$3.46M Buy
94,412
+176
+0.2% +$6.85K 0.98% 35
2023
Q1 		$3.84M Buy
94,236
+4,332
+5% +$187K 1.15% 27
2022
Q4 		$4.61M Buy
89,904
+252
+0.3% +$12.1K 1.47% 22
2022
Q3 		$3.92M Buy
89,652
+1,781
+2% +$86.5K 1.5% 21
2022
Q2 		$4.61M Sell
87,871
-4
-0% -$204 1.68% 14
2022
Q1 		$4.55M Sell
87,875
-3,878
-4% -$201K 1.41% 22
2021
Q4 		$5.42M Buy
91,753
+5,540
+6% +$274K 1.59% 20
2021
Q3 		$3.71M Buy
86,213
+419
+0.5% +$18.6K 1.16% 33
2021
Q2 		$3.36M Buy
85,794
+1,755
+2% +$68.2K 1.03% 39
2021
Q1 		$3.04M Buy
84,039
+2,544
+3% +$90.3K 1.01% 40
2020
Q4 		$3M Buy
81,495
+197
+0.2% +$7.23K 1.02% 37
2020
Q3 		$2.83M Buy
81,298
+3,540
+5% +$124K 1.13% 36
2020
Q2 		$2.41M Buy
77,758
+5,174
+7% +$176K 0.99% 44
2020
Q1 		$2.25M Buy
72,584
+4,616
+7% +$157K 1.14% 30
2019
Q4 		$2.53M Buy
67,968
+5,698
+9% +$203K 1.04% 41
2019
Q3 		$2.12M Sell
62,270
-285
-0.5% -$10.4K 0.94% 44
2019
Q2 		$2.57M Sell
62,555
-1,765
-3% -$70.1K 1.17% 33
2019
Q1 		$2.59M Buy
64,320
+779
+1% +$31.2K 1.21% 29
2018
Q4 		$2.63M Sell
63,541
-315
-0.5% -$13.1K 1.38% 21
2018
Q3 		$2.67M Sell
63,856
-491
-0.8% -$18.9K 1.24% 26
2018
Q2 		$2.21M Sell
64,347
-91
-0.1% -$3.11K 1.09% 32
2018
Q1 		$2.17M Sell
64,438
-15,104
-19% -$519K 1.08% 33
2017
Q4 		$2.73M Buy
79,542
+1,128
+1% +$38.5K 1.37% 25
2017
Q3 		$2.66M Buy
78,414
+1,534
+2% +$49.3K 1.38% 22
2017
Q2 		$2.45M Buy
76,880
+1,637
+2% +$51.6K 1.32% 25
2017
Q1 		$2.44M Buy
75,243
+652
+0.9% +$20.6K 1.44% 25
2016
Q4 		$2.3M Buy
74,591
+594
+0.8% +$18.1K 1.39% 23
2016
Q3 		$2.38M Buy
73,997
+2,392
+3% +$80K 1.51% 20
2016
Q2 		$2.39M Sell
71,605
-541
-0.7% -$17.3K 1.58% 20
2016
Q1 		$2.03M Sell
72,146
-865
-1% -$24.7K 1.38% 26
2015
Q4 		$2.23M Buy
73,011
+459
+0.6% +$14.4K 1.68% 17
2015
Q3 		$2.16M Buy
72,552
+10
+0% +$321 1.74% 15
2015
Q2 		$2.31M Sell
72,542
-64
-0.1% -$2.09K 1.74% 14
2015
Q1 		$2.4M Sell
72,606
-359
-0.5% -$11.4K 1.84% 13
2014
Q4 		$2.15M Buy
72,965
+1,259
+2% +$36.1K 1.72% 21
2014
Q3 		$2.01M Buy
71,706
+2,237
+3% +$62.8K 1.69% 19
2014
Q2 		$1.96M Sell
69,469
-120
-0.2% -$3.42K 1.83% 20
2014
Q1 		$2.12M Buy
69,589
+1,060
+2% +$31.6K 2.05% 11
2013
Q4 		$1.99M Buy
+68,529
New +$1.99M 1.96% 14

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Perkins Coie Trust Company's PFE Position: Q2 2026 in Review

Perkins Coie Trust Company increased its Pfizer (PFE) stake by 1.2% in Q2 2026, buying an estimated $19.5K and bringing the position to 63,473 shares worth $1.53M. The position accounts for 0.25% of the portfolio, ranked #62.

Perkins Coie Trust Company first reported a position in PFE in Q4 2013 and has held it in 51 quarters since. The position peaked at $5.42M in Q4 2021. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Perkins Coie Trust Company held 63,473 shares of Pfizer worth $1.53M as of Q2 2026.
  • Perkins Coie Trust Company bought 747 Pfizer shares in Q2 2026, an estimated $19.5K.
  • Pfizer made up 0.25% of Perkins Coie Trust Company's portfolio in Q2 2026, its #62 holding.
  • Perkins Coie Trust Company first reported a position in Pfizer in Q4 2013 and has held it in 51 quarters since.
  • Perkins Coie Trust Company's Pfizer position peaked at $5.42M in Q4 2021.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Perkins Coie Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.